CHADDS FORD, Pa., Oct. 10 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals Holdings Inc. , a market leader in pain management, will announce its financial results for the third quarter ended September 30, 2006 before the market opens on Thursday, October 19, 2006, and will hold a conference call at 11:00 a.m. ET that day to discuss these results.
Peter A. Lankau, President and Chief Executive Officer, and Joyce LaViscount, Vice President, Financial Operations and Chief Accounting Officer, will host the call.
Investors and other interested parties may access the conference call as follows:
Telephone Numbers Domestic: (866) 831-6272 International: (617) 213-8859 Passcode: 22155304 Please dial in 10 minutes prior to the scheduled start time. Replay
A replay of the call will be available from October 19, 2006 at 1:00 p.m. ET by dialing (888) 286-8010 (domestic) or (617) 801-6888 (international), passcode 88235321 and will run until 12:00 a.m. ET on October 26, 2006.
Webcast
A simultaneous webcast of the call for interested investors and others may be accessed by visiting http://www.endo.com. In addition, a replay of the webcast will be available until 12:00 a.m. ET on October 26, 2006. The replay can be accessed by clicking on "Events" in the Investor Relations section of the website.
About Endo
Endo Pharmaceuticals Holdings Inc. is a fully integrated specialty pharmaceutical company with market leadership in pain management products. Through its Endo Pharmaceuticals Inc. subsidiary, the company researches, develops, produces and markets a broad product offering of branded and generic pharmaceuticals, meeting the needs of healthcare professionals and consumers alike. More information, including this and past press releases of Endo Pharmaceuticals Holdings Inc., is available online at http://www.endo.com.
Endo Pharmaceuticals Holdings Inc.CONTACT: Bill Newbould, Endo Pharmaceuticals, +1-610-558-9800
Web site: http://www.endo.com/
